Pharmacokinetic Profiles of Metformin With DW1029M

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

DW1029M 1200mg and Metformin 1000mg

Metformin 500mg 1 Tablet and DW1029M 300mg 2 Tablets b.i.d. for 7days

DRUG

Metformin 1000mg

Metformin 500mg b.i.d. for 7 days

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju

All Listed Sponsors
lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY